August 18, 2017

Altmetric: 5More detail Article | OPEN Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing


August 11, 2017

Trails and Tribulations

Trails and Tribulations image

[fullwidth background_color=”” background_image=”” background_parallax=”none” enable_mobile=”no” parallax_speed=”0.3″ background_repeat=”no-repeat” background_position=”left top” video_url=”” video_aspect_ratio=”16:9″ video_webm=”” video_mp4=”” video_ogv=”” video_preview_image=”” overlay_color=”” overlay_opacity=”0.5″ video_mute=”yes” video_loop=”yes” fade=”no” border_size=”0px” border_color=”” border_style=”” padding_top=”20″ padding_bottom=”20″ padding_left=”” padding_right=”” hundred_percent=”no” equal_height_columns=”no” hide_on_mobile=”no” menu_anchor=”” class=”” id=””][two_third last=”no” spacing=”yes” center_content=”no” hide_on_mobile=”no” background_color=”” background_image=”” background_repeat=”no-repeat” background_position=”left top” hover_type=”none” link=”” border_position=”all” border_size=”0px” border_color=”” border_style=”” padding=”” margin_top=”” margin_bottom=”” animation_type=”” animation_direction=”” animation_speed=”0.1″ animation_offset=””…


August 4, 2017

Subaru and Leukemia & Lymphoma Society Blanket Myeloma Institute with Love

Subaru of Little Rock and the Leukemia & Lymphoma Society brought blankets to be given to patients for comfort.

Aug. 4, 2017 | Patients of the UAMS Myeloma Institute will soon be wrapped in additional care and comfort, thanks to the Subaru Loves to Care initiative launched last year by the vehicle manufacturer in partnership with the Leukemia & Lymphoma Society. As part of the nationwide initiative, employees from the Subaru of Little Rock dealership and…


July 27, 2017

From the Director

Gareth Morgan, M.D., Ph.D

Dear Readers, Quality of life for patients is a top priority at the Myeloma Institute.  Our team is committed to providing a comprehensive, holistic experience, including effective disease management and emotional support for patients, family members and caregivers. We believe that patients should be able to live their lives as fully as possible with minimal…


Bone Disease in Myeloma

Donghoon Yoon, Ph.D., in his lab where his focus is on the factors and mechanisms of bone metabolism in myeloma

Donghoon Yoon, Ph.D., in his lab where his focus is on the factors and mechanisms of bone metabolism in myeloma Bone disease is a hallmark of myeloma, affecting up to 90 percent of patients. An unexplained fracture or bone pain can be the first sign that something is not right and often leads patients to…


Bone Remodeling Clinical Trial Assessment

Carolina Schinke, M.D., assistant professor, conducts research that leads to development of new clinical trials.

Carolina Schinke, M.D., assistant professor, conducts research that leads to development of new clinical trials. Bone disease is a major issue for the majority of multiple myeloma patients.  Lytic lesions, fractures and collapse of vertebra in the spine — primary causes of pain and debilitation — can significantly compromise quality of life. Clinical treatment for…


Partners in Care

Bobbie Rainey receiving a post-surgery exam by orthopaedic surgeon Corey Montgomery, M.D.

Bobbie Rainey receiving a post-surgery exam by orthopaedic surgeon Corey Montgomery, M.D. Bobbie Rainey from Gould, Arkansas, came to the Myeloma Institute in September of 2010.  She was experiencing pain all over her body, especially her lower back, legs and arms, in addition to other symptoms of myeloma. Due to a persistent bone lesion in…


Plasma Cell Neoplasm — A Brief Primer

Myeloma Cell

While multiple myeloma is the primary disease treated at the Myeloma Institute, other plasma cell neoplasms are also the focus of our research and treatment regimens. What is a Plasma Cell Neoplasm? A neoplasm is an abnormal mass of tissue that results when cells divide more than they should or do not die when they…


publications

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker A new publication in Blood Cancer Journal 24 February 2017, PMID: 28234347 Primary Authors: Shweta Chavan, Ph.D., and Brian Walker, Ph.D. Targeted gene sequencing was conducted on 578 cases of plasma cell neoplasms, including monoclonal gammopathy of undermined…


Giving Back and Creating a Legacy

Giving Back

The Myeloma Institute is a trailblazer in the development of innovative treatments for myeloma and other plasma cell neoplasms. With a firm commitment to helping patients regain their lives and look forward to a disease-free future, the institute’s health care team provides expertise while extending compassion and encouragement. Patients and families frequently ask how they…



Previous page Next page